Joseph Scheeren - 10 Jun 2025 Form 4 Insider Report for Barinthus Biotherapeutics plc. (BRNS)

Role
Director
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
BRNS
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 17:13:23 UTC
Previous filing
14 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scheeren Joseph Director UNIT 6-10, ZEUS BUILDING, RUTHERFORD AVENUE, HARWELL, DIDCOT, UNITED KINGDOM /s/ William Enright, Attorney-in-Fact 11 Jun 2025 0001852070

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRNS Share Option (Right to Buy) Award $0 +20,174 $0.000000 20,174 10 Jun 2025 Ordinary Shares 20,174 $1.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.